litlas
Log inCreate account

Vinod K. Rustgi

Active 1984–2024

Also published as
VINOD K. RUSTGI
57
Papers
18,169
Citations
39
h-index
57
i10-index

Citations

Citations per year for Vinod K. Rustgi1986: 3 citations1987: 4 citations1988: 3 citations1989: 12 citations1990: 11 citations1991: 23 citations1992: 18 citations1993: 32 citations1994: 23 citations1995: 18 citations1996: 10 citations1997: 14 citations1998: 20 citations1999: 68 citations2000: 119 citations2001: 119 citations2002: 187 citations2003: 171 citations2004: 171 citations2005: 178 citations2006: 161 citations2007: 140 citations2008: 104 citations2009: 96 citations2010: 111 citations2011: 82 citations2012: 102 citations2013: 109 citations2014: 91 citations2015: 114 citations2016: 91 citations2017: 60 citations2018: 48 citations2019: 109 citations2020: 113 citations2021: 106 citations2022: 135 citations2023: 115 citations2024: 172 citations2025: 122 citations2026: 4 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,301 citing papers, 28.8% of this breakdownFrance: 316 citing papers, 7% of this breakdownGermany: 312 citing papers, 6.9% of this breakdownUnited Kingdom: 251 citing papers, 5.6% of this breakdownItaly: 241 citing papers, 5.3% of this breakdownChina: 222 citing papers, 4.9% of this breakdownJapan: 195 citing papers, 4.3% of this breakdownCanada: 160 citing papers, 3.5% of this breakdownSpain: 156 citing papers, 3.5% of this breakdownAustralia: 124 citing papers, 2.7% of this breakdownSwitzerland: 86 citing papers, 1.9% of this breakdownTaiwan: 82 citing papers, 1.8% of this breakdown
0%28.8%Other 23.8%

Institutions

Fields

  • Medicine86.9%
  • Biochemistry, Genetics and Molecular Biology3.9%
  • Computer Science2.1%
  • Immunology and Microbiology1.9%
  • Neuroscience1.6%
  • Nursing0.9%
  • Other2.7%

Topics

  • Hepatitis C virus research21.6%
  • Hepatitis B Virus Studies12.1%
  • Liver Disease Diagnosis and Treatment11.9%
  • HIV/AIDS drug development and treatment3.7%
  • Liver Disease and Transplantation3.2%
  • Hepatitis Viruses Studies and Epidemiology3%
  • Other44.5%

Coauthors

All papers

Open in search
  1. Genetic mutation and biological pathway prediction based on whole slide images in breast carcinoma using deep learning

    Authors: Hui Qu, Mu Zhou, Zhennan Yan, He Wang, Vinod K. Rustgi, Shaoting Zhang, Olivier Gevaert, Dimitris Metaxas - npj Precision Oncology 2021 cited by 117

  2. Impacts of glucagon‐like peptide‐1 receptor agonists on the risk of adverse liver outcomes in patients with metabolic dysfunction‐associated steatotic liver disease cirrhosis and type 2 diabetes

    Authors: Mohamed I. Elsaid, Na Li, Stephen A. Firkins, Vinod K. Rustgi, Electra D. Paskett, Chathur Acharya, K. Rajender Reddy, Chien Wei Chiang, Khalid Mumtaz - Alimentary Pharmacology & Therapeutics 2024 cited by 67

  3. Bariatric Surgery Reduces Cancer Risk in Adults With Nonalcoholic Fatty Liver Disease and Severe Obesity

    Authors: Vinod K. Rustgi, You Li, Kapil Gupta, Carlos D. Minacapelli, Abhishek Bhurwal, Carolyn Catalano, Mohamed I. Elsaid - Gastroenterology 2021 cited by 123

  4. Association of Bariatric Surgery With Cardiovascular Outcomes in Adults With Severe Obesity and Nonalcoholic Fatty Liver Disease

    Authors: Mohamed I. Elsaid, You Li, John F. P. Bridges, Guy Brock, Carlos D. Minacapelli, Vinod K. Rustgi - JAMA Network Open 2022 cited by 57

  5. Epidemiology of Hepatic Encephalopathy

    Authors: Mohamed I. Elsaid, Vinod K. Rustgi - Clinics in Liver Disease 2020 cited by 100

  6. At the Interface of Lifestyle, Behavior, and Circadian Rhythms: Metabolic Implications

    Authors: Seul-A. Bae, Ming Zhu Fang, Vinod K. Rustgi, Helmut Zarbl, Ioannis P. Androulakis - Frontiers in Nutrition 2019 cited by 97

  7. Circadian Rhythms, the Gut Microbiome, and Metabolic Disorders

    Authors: Eric Zhao, Christopher Tait, Carlos D. Minacapelli, Carolyn Catalano, Vinod K. Rustgi - Gastro Hep Advances 2022 cited by 52

  8. Inverse Association of Coffee with Liver Cancer Development: An Updated Systematic Review and Meta-analysis

    Authors: Abhishek Bhurwal, Puru Ratta, Sho Yoshitake, Lauren Pioppo, Debashish Reja, Peter Dellatore, Vinod K. Rustgi - Journal of Gastrointestinal and Liver Diseases 2020 cited by 59

  9. Validation of a Clinical Risk-based Classification System in a Large Nonalcoholic Fatty Liver Disease Real-world Cohort

    Authors: Arun J. Sanyal, Breda Muñoz, Kenneth Cusi, A. Sidney Barritt, Mark Muthiah, Andrea R. Mospan, K. Rajender Reddy, Roberto Firpi-Morell, Paul J. Thuluvath, Kalyan Ram Bhamidimarri, Michael Fried, Manal F. Abdelmalek, Humberto Aguilar, Aijaz Ahmed, Alina M. Allen, Sarah E. Barlow, Sid Barritt, David Bernstein, Kaylan Bhamidimarri, Liana K. Billings, Kyle Brown, Robert H. Brown, Karen D. Corbin, Kenneth Cusi, Andrew S. deLemos, Karan M. Emerick, Roberto Firpi-Morell, Maged Adel Ghali, Zachary Henry, Whitney E. Jackson, Sujit Janardhan, M. Kabbany, Nyingi Kemmer, David Koch, Justin Kupec, Charles Landis, Mary Katherine Lawrence, Cynthia Levy, Steven D. Lidofsky, Anna S. Lok, Velimir A. Luketic, Enrique Martinez, Craig J. McClain, Patrick McKiernan, Ellen Mitchell, Mazen Noureddin, Sirish Palle, Yen Pham, David Pound, K. Rajender Reddy, Fredric Regenstein, Mary E. Rinella, Fedja A. Rochling, Bryan Rudolph, Vinod K. Rustgi, Adnan Said, Niharika Samala, Souvik Sarkar, Kenneth E. Sherman, Mitchell Shiffman, Coleman Smith, Jawahar Taunk, Brent Tetri, Paul J. Thuluvath, Huy N. Trinh, Elizabeth C. Verna, Miriam B. Vos, Laurence Weiss, Mark Yu Zheng Wong, Kathleen Wyne, Stavra A. Xanthakos - Clinical Gastroenterology and Hepatology 2023 cited by 18

  10. A randomized phase 2b study of peginterferon lambda-1a for the treatment of chronic HCV infection

    Authors: Andrew J. Muir, Sanjeev Arora, Gregory T. Everson, Robert Flisiak, Jacob George, Reem Ghalib, Stuart C. Gordon, Todd Gray, Susan Greenbloom, Tarek Hassanein, Jan Hillson, Maria Arantxa Horga, Ira M. Jacobson, Lennox Jeffers, Kris V. Kowdley, Eric Lawitz, Stefan Lueth, M. Rodríguez‐Torres, Vinod K. Rustgi, Lynn Shemanski, Mitchell L. Shiffman, Subasree Srinivasan, Hugo E. Vargas, John M. Vierling, Dong Xu, Juan Carlos López-Talavera, Stefan Zeuzem - Journal of Hepatology 2014 cited by 147

  11. Acute kidney injury and hepatorenal syndrome in cirrhosis

    Authors: Kapil Gupta, Abhishek Bhurwal, C.K. Law, Scott Ventre, Carlos D. Minacapelli, Savan Kabaria, You Li, Christopher Tait, Carolyn Catalano, Vinod K. Rustgi - World Journal of Gastroenterology 2021 cited by 74

  12. Drug-induced liver injury associated with antiseizure medications from the FDA Adverse Event Reporting System (FAERS)

    Authors: Brad K. Kamitaki, Carlos D. Minacapelli, Pengfei Zhang, Christopher Wachuku, Kapil Gupta, Carolyn Catalano, Vinod K. Rustgi - Epilepsy & Behavior 2021 cited by 57

  13. Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis

    Authors: Kris V. Kowdley, Stuart C. Gordon, K. Rajender Reddy, Lorenzo Rossaro, David Bernstein, Eric Lawitz, Mitchell L. Shiffman, Eugene R. Schiff, Reem Ghalib, Michael J. Ryan, Vinod K. Rustgi, Mario Chojkier, Robert Herring, Adrian M. Di Bisceglie, Paul J. Pockros, G. Mani Subramanian, Di An, Evguenia S. Svarovskaia, Robert H. Hyland, Phillip S. Pang, William T. Symonds, John G. McHutchison, Andrew J. Muir, David Pound, Michael Fried - New England Journal of Medicine 2014 cited by 1,125

  14. Increased serum selenium levels are associated with reduced risk of advanced liver fibrosis and all-cause mortality in NAFLD patients: National Health and Nutrition Examination Survey (NHANES) III

    Authors: Mishal Reja, Michael Makar, Aayush Visaria, Daniel Marino, Vinod K. Rustgi - Annals of Hepatology 2020 cited by 45

  15. Targeting hepatic kisspeptin receptor ameliorates nonalcoholic fatty liver disease in a mouse model

    Authors: Stephania Guzman, Magdalena Dragan, Hyokjoon Kwon, Vanessa de Oliveira, Shivani Rao, Vrushank Bhatt, Katarzyna M. Kalemba, Ankit Shah, Vinod K. Rustgi, He Wang, Paul R. Bech, Ali Abbara, Chioma Izzi-Engbeaya, Pinelopi Manousou, Jessie Y. Guo, Grace L. Guo, Sally Radovick, Waljit S. Dhillo, Fredric E. Wondisford, Andy V. Babwah, Moshmi Bhattacharya - Journal of Clinical Investigation 2022 cited by 39

  16. Nonalcoholic Fatty Liver Disease in Lean/Nonobese and Obese Individuals: A Comprehensive Review on Prevalence, Pathogenesis, Clinical Outcomes, and Treatment

    Authors: Ankoor Patel, Dhiraj Peddu, Sahil Amin, Mohamed I. Elsaid, Carlos D. Minacapelli, Toni-Marie Chandler, Carolyn Catalano, Vinod K. Rustgi - Journal of Clinical and Translational Hepatology 2022 cited by 32

  17. Economic and Health Care Burdens of Hepatitis Delta: A Study of Commercially Insured Adults in the United States

    Authors: Mohamed I. Elsaid, You Li, T.M. John, Navaneeth Narayanan, Carolyn Catalano, Vinod K. Rustgi - Hepatology 2019 cited by 28

  18. Cost-effectiveness and potential value of pharmaceutical treatment of nonalcoholic fatty liver disease

    Authors: Vinod K. Rustgi, Steve Duff, Mohamed I. Elsaid - Journal of Medical Economics 2022 cited by 22

  19. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

    Authors: Michael P. Manns, John G. McHutchison, Stuart C. Gordon, Vinod K. Rustgi, Mitchell L. Shiffman, Robert Reindollar, Zachary Goodman, Kenneth Koury, Mei–Hsiu Ling, Janice K. Albrecht - The Lancet 2001 cited by 6,052

  20. Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C

    Authors: John G. McHutchison, Stuart C. Gordon, Eugene R. Schiff, Mitchell L. Shiffman, William M. Lee, Vinod K. Rustgi, Zachary Goodman, Mei–Hsiu Ling, Susannah Cort, Janice K. Albrecht - New England Journal of Medicine 1998 cited by 3,500

  21. Treatment of Chronic Non-A, Non-B Hepatitis with Recombinant Human Alpha Interferon

    Authors: Jay H. Hoofnagle, Kevin D. Mullen, D B Jones, Vinod K. Rustgi, Adrian M. Di Bisceglie, Marion G. Peters, Jeanne G. Waggoner, Yoon Park, E. Anthony Jones - New England Journal of Medicine 1986 cited by 977

  22. Alterations of the fecal microbiota in relation to acute COVID-19 infection and recovery

    Authors: Yue Yin, Carlos D. Minacapelli, Veenat Parmar, Carolyn C. Catalano, Abhishek Bhurwal, Kapil Gupta, Vinod K. Rustgi, Martin J. Blaser - Molecular Biomedicine 2022 cited by 28

  23. Blood lead level is associated with advanced liver fibrosis in patients with non-alcoholic fatty liver disease: A nationwide survey (NHANES 2011–2016)

    Authors: Debashis Reja, Michael Makar, Aayush Visaria, Briette Karanfilian, Vinod K. Rustgi - Annals of Hepatology 2020 cited by 37

  24. The Microbiome and Hepatocellular Carcinoma

    Authors: Puru Rattan, Carlos D. Minacapelli, Vinod K. Rustgi - Liver Transplantation 2020 cited by 32